Valérie Vial
5PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 03, 2025
De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma.Manon Teisseire, Umakant Sahu, Julien Parola
|Nov 26, 2024
Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis.Célia Gotorbe, Fabien Segui, William Echavidre
|Nov 27, 2023
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.William Echavidre, Jérôme Durivault, Célia Gotorbe
|Jan 11, 2022
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma.Marina Pagnuzzi-Boncompagni, Vincent Picco, Valérie Vial
|Jun 02, 2021
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.Aurore Dumond, Christopher Montemagno, Valérie Vial
Pageof 1
Frequent Collaborators
4 joint publications
Christopher Montemagno
4 joint publications
Jérôme Durivault
3 joint publications
Gilles Pagès
3 joint publications
Vincent Picco
2 joint publications
Benjamin Serrano
2 joint publications
Rémy Villeneuve
1 joint publications
Renaud Grépin
1 joint publications
Thomas Daubon
1 joint publications
Sandy Giuliano
1 joint publications
Julie Gavard
